{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:23:11Z","timestamp":1790785391821,"version":"4.1.0"},"reference-count":28,"publisher":"SAGE Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2021,8,3]]},"abstract":"<jats:p>Plasma neurofilament light chain (NfL) is a marker of neuronal damage in different neurological disorders and might predict disease progression in dementia with Lewy bodies (DLB). The study enrolled 45 controls and 44 DLB patients (including 17 prodromal cases) who underwent an extensive assessment at baseline and at 2 years follow-up. At baseline, plasma NfL levels were higher in both probable DLB and prodromal cases compared to controls. Plasma NfL emerged as the best predictor of cognitive decline compared to age, sex, and baseline severity variables. The study supports the role of plasma NfL as a useful prognostic biomarker from the early stages of DLB.<\/jats:p>","DOI":"10.3233\/jad-210342","type":"journal-article","created":{"date-parts":[[2021,6,15]],"date-time":"2021-06-15T14:03:27Z","timestamp":1623765807000},"page":"913-919","source":"Crossref","is-referenced-by-count":48,"title":["Plasma Neurofilament Light Chain Predicts Cognitive Progression in Prodromal and Clinical Dementia with Lewy Bodies"],"prefix":"10.1177","volume":"82","author":[{"given":"Andrea","family":"Pilotto","sequence":"first","affiliation":[{"name":"Neurology Unit, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy"},{"name":"FERB Onlus, Ospedale S. Isidoro, Trescore Balneario, Bergamo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Imarisio","sequence":"additional","affiliation":[{"name":"Neurology Unit, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Carrarini","sequence":"additional","affiliation":[{"name":"Department of Neuroscience Imaging and Clinical Sciences, University G. d\u2019Annunzio of Chieti-Pescara, Chieti, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirella","family":"Russo","sequence":"additional","affiliation":[{"name":"Department of Neuroscience Imaging and Clinical Sciences, University G. d\u2019Annunzio of Chieti-Pescara, Chieti, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Masciocchi","sequence":"additional","affiliation":[{"name":"Neurology Unit, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Gipponi","sequence":"additional","affiliation":[{"name":"Neurology Unit, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Cottini","sequence":"additional","affiliation":[{"name":"Neurology Unit, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dag","family":"Aarsland","sequence":"additional","affiliation":[{"name":"Centre for Age-Related Medicine, Stavanger University Hospital, Stavanger, Norway"},{"name":"Department of Old Age Psychiatry, Institute of Psychiatry, Psychology & Neuroscience, Maurice Wohl Clinical Neuroscience Institute, King\u2019s College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Zetterberg","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden"},{"name":"Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, M\u00f6lndal, Sweden"},{"name":"Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK"},{"name":"UK Dementia Research Institute at UCL, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas J.","family":"Ashton","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden"},{"name":"Wallenberg Centre for Molecular and Translational Medicine, Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, Sweden"},{"name":"Department of Old Age Psychiatry, Institute of Psychiatry, Psychology & Neuroscience, Maurice Wohl Clinical Neuroscience Institute, King\u2019s College London, London, UK"},{"name":"NIHR Biomedical Research Centre for Mental Health & Biomedical Research Unit for Dementia at South London & Maudsley NHS Foundation, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul","family":"Hye","sequence":"additional","affiliation":[{"name":"Department of Old Age Psychiatry, Institute of Psychiatry, Psychology & Neuroscience, Maurice Wohl Clinical Neuroscience Institute, King\u2019s College London, London, UK"},{"name":"NIHR Biomedical Research Centre for Mental Health & Biomedical Research Unit for Dementia at South London & Maudsley NHS Foundation, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Bonanni","sequence":"additional","affiliation":[{"name":"Department of Neuroscience Imaging and Clinical Sciences, University G. d\u2019Annunzio of Chieti-Pescara, Chieti, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Padovani","sequence":"additional","affiliation":[{"name":"Neurology Unit, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-210342_ref1","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/S0140-6736(15)00462-6","article-title":"Lewy body dementias","volume":"386","author":"Walker","year":"2015","journal-title":"Lancet"},{"key":"10.3233\/JAD-210342_ref2","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","article-title":"Diagnosis and management of dementia with Lewy bodies","volume":"89","author":"McKeith","year":"2017","journal-title":"Neurology"},{"key":"10.3233\/JAD-210342_ref3","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1212\/WNL.0000000000009323","article-title":"Research criteria for the diagnosis of prodromal dementia with Lewy bodies","volume":"94","author":"McKeith","year":"2020","journal-title":"Neurology"},{"key":"10.3233\/JAD-210342_ref4","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1136\/jnnp-2019-320846","article-title":"Orthostatic hypotension and REM sleep behaviour disorder: Impact on clinical outcomes in \u03b1-synucleinopathies","volume":"90","author":"Pilotto","year":"2019","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.3233\/JAD-210342_ref5","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/S1474-4422(17)30074-1","article-title":"The prognosis of dementia with Lewy bodies","volume":"16","author":"Mueller","year":"2017","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-210342_ref6","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.3233\/JAD-190731","article-title":"Greater variability in cognitive decline in Lewy body dementia compared to Alzheimer\u2019s disease","volume":"73","author":"Giil","year":"2020","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-210342_ref7","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.1038\/s41467-021-23620-z","article-title":"Diagnostic value of plasma neurofilament light: A multicentre validation study","volume":"12","author":"Ashton","year":"2021","journal-title":"Nat Commun"},{"key":"10.3233\/JAD-210342_ref8","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1002\/mds.28206","article-title":"Validation of serum neurofilament light chain as a biomarker of Parkinson\u2019s disease progression","volume":"35","author":"Mollenhauer","year":"2020","journal-title":"Mov Disord"},{"key":"10.3233\/JAD-210342_ref9","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1001\/jamaneurol.2019.1534","article-title":"Diagnostic value of cerebrospinal fluid neurofilament light protein in neurology: A systematic review and meta-analysis","volume":"76","author":"Bridel","year":"2019","journal-title":"JAMA Neurol"},{"key":"10.3233\/JAD-210342_ref10","doi-asserted-by":"crossref","first-page":"e1104","DOI":"10.1212\/WNL.0000000000008088","article-title":"Blood NfL: A biomarker for disease severity and progression in Parkinson disease","volume":"93","author":"Lin","year":"2019","journal-title":"Neurology"},{"key":"10.3233\/JAD-210342_ref11","doi-asserted-by":"crossref","first-page":"e827","DOI":"10.1212\/WNL.0000000000010084","article-title":"NfL as a biomarker for neurodegeneration and survival in Parkinson disease","volume":"95","author":"B\u00e4ckstr\u00f6m","year":"2020","journal-title":"Neurology"},{"key":"10.3233\/JAD-210342_ref12","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1001\/jamaneurol.2020.4986","article-title":"Longitudinal associations of blood phosphorylated Tau181 and neurofilament light chain with neurodegeneration in Alzheimer disease","volume":"78","author":"Moscoso","year":"2021","journal-title":"JAMA Neurol"},{"key":"10.3233\/JAD-210342_ref13","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1007\/s00259-019-04324-5","article-title":"Extrastriatal dopaminergic and serotonergic pathways in Parkinson\u2019s disease and in dementia with Lewy bodies: A 123I-FP-CIT SPECT study","volume":"46","author":"Pilotto","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.3233\/JAD-210342_ref14","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1002\/mds.23429","article-title":"Systematic review of levodopa dose equivalency reporting in Parkinson\u2019s disease","volume":"25","author":"Tomlinson","year":"2010","journal-title":"Mov Disord"},{"key":"10.3233\/JAD-210342_ref15","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1002\/mds.22340","article-title":"Movement Disorder Society-sponsored revision of the Unified Parkinson\u2019s Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results","volume":"23","author":"Goetz","year":"2008","journal-title":"Mov Disord"},{"issue":"5 Suppl 6","key":"10.3233\/JAD-210342_ref16","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1212\/WNL.48.5_Suppl_6.10S","article-title":"The Neuropsychiatric Inventory: Assessing psychopathology in dementia patients","volume":"48","author":"Cummings","year":"1997","journal-title":"Neurology"},{"key":"10.3233\/JAD-210342_ref17","doi-asserted-by":"crossref","first-page":"563","DOI":"10.3233\/JAD-150610","article-title":"Vascular risk factors and cognition in Parkinson\u2019s disease","volume":"51","author":"Pilotto","year":"2016","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-210342_ref18","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/ana.24954","article-title":"Serum neurofilament light: A biomarker of neuronal damage in multiple sclerosis","volume":"81","author":"Disanto","year":"2017","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-210342_ref19","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1023\/B:AIRE.0000045502.10941.a9","article-title":"A survey of outlier detection methodologies","volume":"22","author":"Hodge","year":"2004","journal-title":"Artif Intell Rev"},{"key":"10.3233\/JAD-210342_ref20","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.neuron.2016.05.018","article-title":"Neurofilament light chain in blood and CSF as marker of disease progression in mouse models and in neurodegenerative diseases","volume":"91","author":"Bacioglu","year":"2016","journal-title":"Neuron"},{"key":"10.3233\/JAD-210342_ref21","doi-asserted-by":"crossref","first-page":"9161","DOI":"10.1038\/s41598-020-66090-x","article-title":"Differential levels of neurofilament light protein in cerebrospinal fluid in patients with a wide range of neurodegenerative disorders","volume":"10","author":"Delaby","year":"2020","journal-title":"Sci Rep"},{"key":"10.3233\/JAD-210342_ref22","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.neurobiolaging.2014.07.009","article-title":"Quantitative electroencephalogram utility in predicting conversion of mild cognitive impairment to dementia with Lewy bodies","volume":"36","author":"Bonanni","year":"2015","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-210342_ref23","doi-asserted-by":"crossref","first-page":"e662","DOI":"10.1212\/WNL.0000000000009977","article-title":"Diagnostic and prognostic value of EEG in prodromal dementia with Lewy bodies","volume":"95","author":"van der Zande","year":"2020","journal-title":"Neurology"},{"key":"10.3233\/JAD-210342_ref24","doi-asserted-by":"crossref","first-page":"e1916439","DOI":"10.1001\/jamanetworkopen.2019.16439","article-title":"Association of longitudinal \u03b2-amyloid accumulation determined by positron emission tomography with clinical and cognitive decline in adults with probable Lewy body dementia","volume":"2","author":"Nedelska","year":"2019","journal-title":"JAMA Netw Open"},{"key":"10.3233\/JAD-210342_ref25","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1001\/jamaneurol.2018.3746","article-title":"Association of cerebrospinal fluid neurofilament light protein levels with cognition in patients with dementia, motor neuron disease, and movement disorders","volume":"76","author":"Olsson","year":"2019","journal-title":"JAMA Neurol"},{"key":"10.3233\/JAD-210342_ref26","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13195-017-0331-1","article-title":"The CSF neurofilament light signature in rapidly progressive neurodegenerative dementias","volume":"10","author":"Abu-Rumeileh","year":"2018","journal-title":"Alzheimers Res Ther"},{"key":"10.3233\/JAD-210342_ref27","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1002\/mds.27731","article-title":"Dementia with lewy bodies: GBA1 mutations are associated with cerebrospinal fluid alpha-synuclein profile","volume":"34","author":"Lerche","year":"2019","journal-title":"Mov Disord"},{"key":"10.3233\/JAD-210342_ref28","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1002\/mds.26668","article-title":"Alzheimer\u2019s disease cerebrospinal fluid biomarkers predict cognitive decline in Lewy body dementia","volume":"31","author":"Abdelnour","year":"2016","journal-title":"Mov Disord"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-210342","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:06:15Z","timestamp":1777370775000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-210342"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,3]]},"references-count":28,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.3233\/jad-210342","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.03.19.21253993","asserted-by":"object"}]},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,3]]}}}